Adverum Biotechnologies Stock Price on December 30, 2022
| ADVM Stock | USD 11.34 0.19 1.70% |
Below is the normalized historical share price chart for Adverum Biotechnologies extending back to July 31, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Adverum Biotechnologies stands at 11.34, as last reported on the 23rd of April, with the highest price reaching 11.72 and the lowest price hitting 11.22 during the day.
If you're considering investing in Adverum Stock, it is important to understand the factors that can impact its price. Adverum Biotechnologies appears to be unstable, given 3 months investment horizon. Adverum Biotechnologies secures Sharpe Ratio (or Efficiency) of 0.0822, which signifies that the company had a 0.0822% return per unit of risk over the last 3 months. By analyzing Adverum Biotechnologies' technical indicators, you can evaluate if the expected return of 0.76% is justified by implied risk. Please makes use of Adverum Biotechnologies' Downside Deviation of 6.34, mean deviation of 5.57, and Risk Adjusted Performance of 0.0654 to double-check if our risk estimates are consistent with your expectations.
At this time, Adverum Biotechnologies' Common Stock Shares Outstanding is very stable compared to the past year. As of the 23rd of April 2024, Liabilities And Stockholders Equity is likely to grow to about 247.9 M, while Other Stockholder Equity is likely to drop about 567.3 M. . At this time, Adverum Biotechnologies' Price Book Value Ratio is very stable compared to the past year. As of the 23rd of April 2024, Price Earnings To Growth Ratio is likely to grow to 0.03, while Price Earnings Ratio is likely to drop (0.68). Adverum Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 31st of July 2014 | 200 Day MA 13.9108 | 50 Day MA 16.3366 | Beta 0.793 |
Adverum |
Sharpe Ratio = 0.0822
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ADVM | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 9.23 actual daily | 81 81% of assets are less volatile |
Expected Return
| 0.76 actual daily | 14 86% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Adverum Biotechnologies is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Adverum Biotechnologies by adding it to a well-diversified portfolio.
Price Book 2.9167 | Enterprise Value Ebitda (1.88) | Price Sales 67.6264 | Shares Float 11.7 M | Wall Street Target Price 40 |
Adverum Biotechnologies Valuation on December 30, 2022
It is possible to determine the worth of Adverum Biotechnologies on a given historical date. On December 30, 2022 Adverum was worth 0.57 at the beginning of the trading date compared to the closed value of 5.8. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Adverum Biotechnologies stock. Still, in general, we apply an absolute valuation method to find Adverum Biotechnologies' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Adverum Biotechnologies where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Adverum Biotechnologies' related companies.
| Open | High | Low | Close | Volume | |
| 0.57 | 5.90 | 5.90 | 5.90 | 26,569 | |
12/30/2022 | 0.57 | 5.80 | 5.80 | 5.80 | 44,574 |
| 0.61 | 6.40 | 6.40 | 6.40 | 26,930 |
| Backtest Adverum Biotechnologies | | | Adverum Biotechnologies History | | | Adverum Biotechnologies Valuation | Previous | Next |
Adverum Biotechnologies Trading Date Momentum on December 30, 2022
| On January 03 2023 Adverum Biotechnologies was traded for 6.40 at the closing time. The top price for the day was 6.40 and the lowest listed price was 6.40 . The trading volume for the day was 26.9 K. The trading history from January 3, 2023 was a factor to the next trading day price boost. The overall trading delta against the next closing price was 10.34% . The overall trading delta against the current closing price is 88.79% . |
Adverum Biotechnologies Fundamentals Correlations and Trends
By evaluating Adverum Biotechnologies' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Adverum Biotechnologies' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Adverum financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Adverum Biotechnologies Stock history
Adverum Biotechnologies investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Adverum is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Adverum Biotechnologies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Adverum Biotechnologies stock prices may prove useful in developing a viable investing in Adverum Biotechnologies
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 10.1 M | 18.4 M | |
| Net Loss | -139.1 M | -146 M |
Adverum Biotechnologies Quarterly Net Working Capital |
|
Adverum Biotechnologies Stock Technical Analysis
Adverum Biotechnologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Adverum Biotechnologies Period Price Range
Low | December 30, 2022
| High |
0.57 | 5.80 |
Adverum Biotechnologies April 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Adverum Biotechnologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Adverum Biotechnologies shares will generate the highest return on investment. By undertsting and applying Adverum Biotechnologies stock market strength indicators, traders can identify Adverum Biotechnologies entry and exit signals to maximize returns
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 10.18 | |||
| Day Median Price | 5.8 | |||
| Day Typical Price | 5.8 | |||
| Price Action Indicator | 2.62 | |||
| Period Momentum Indicator | 5.54 | |||
| Relative Strength Index | 34.22 |
Adverum Biotechnologies Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Adverum Biotechnologies' price direction in advance. Along with the technical and fundamental analysis of Adverum Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Adverum to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0654 | |||
| Jensen Alpha | 0.8117 | |||
| Total Risk Alpha | (0.35) | |||
| Sortino Ratio | 0.1147 | |||
| Treynor Ratio | (11.47) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adverum Biotechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Adverum Stock analysis
When running Adverum Biotechnologies' price analysis, check to measure Adverum Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adverum Biotechnologies is operating at the current time. Most of Adverum Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adverum Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adverum Biotechnologies' price. Additionally, you may evaluate how the addition of Adverum Biotechnologies to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |
Is Adverum Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.60) | Revenue Per Share 0.357 | Quarterly Revenue Growth (0.70) | Return On Assets (0.32) | Return On Equity (0.88) |
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.